ChronoScale Corporation Common Stock (NASDAQ:CHRN – Get Free Report)’s stock price crossed above its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $15.85 and traded as high as $17.72. ChronoScale Corporation Common Stock shares last traded at $17.49, with a volume of 247,811 shares trading hands.
Wall Street Analysts Forecast Growth
A number of brokerages have recently commented on CHRN. Weiss Ratings lowered shares of ChronoScale Corporation Common Stock from a “sell (d)” rating to a “sell (d-)” rating in a report on Friday, October 23rd. Compass Point started coverage on shares of ChronoScale Corporation Common Stock in a research report on Friday, October 16th. They set a “buy” rating and a $25.00 price target on the stock. Finally, Northland Securities started coverage on ChronoScale Corporation Common Stock in a report on Friday, September 18th. They issued an “outperform” rating and a $32.00 price objective on the stock. Two analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $21.00.
Check Out Our Latest Stock Analysis on CHRN
ChronoScale Corporation Common Stock Price Performance
The business’s 50-day simple moving average is $18.97 and its 200-day simple moving average is $15.90. The stock has a market cap of $2.27 billion, a PE ratio of -3.61 and a beta of 0.98. The company has a quick ratio of 0.30, a current ratio of 0.30 and a debt-to-equity ratio of 0.02.
ChronoScale Corporation Common Stock (NASDAQ:CHRN – Get Free Report) last posted its earnings results on Wednesday, October 14th. The company reported ($0.29) earnings per share for the quarter. The firm had revenue of $41.48 million for the quarter. ChronoScale Corporation Common Stock had a negative return on equity of 66.16% and a negative net margin of 135.66%. On average, research analysts expect that ChronoScale Corporation Common Stock will post -0.49 EPS for the current fiscal year.
ChronoScale Corporation Common Stock Company Profile
Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods.
Further Reading
- Five stocks we like better than ChronoScale Corporation Common Stock
- Phillips 66 Posts Strong Earnings But the Stock Doesn’t Care
- NXP Semiconductors Falls After Strong Earnings—Is the Sell-Off Overdone?
- GE Vernova’s Reservations Are Turning Into Real Orders—But the Market Still Wants More.
- Where’s the Beef? Trian-Led Buyout Proposal Values Wendy’s at $1.4B, But Is It Enough?
Receive News & Ratings for ChronoScale Corporation Common Stock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ChronoScale Corporation Common Stock and related companies with MarketBeat.com's FREE daily email newsletter.
